Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era

Annelot F Schoffelen1, Colette Smit2, Steven F L van Lelyveld3

  • 1Department of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht.

Insights

In HIV-infected individuals, being of Sub-Saharan African origin was linked to higher initial chronic kidney disease (CKD) rates. However, ethnicity did not affect the risk of developing new CKD over time, suggesting changing causes.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is a significant comorbidity in human immunodeficiency virus (HIV) infection.
  • Historically, HIV-associated nephropathy was the primary cause of CKD, particularly in individuals of African ancestry.
  • Recent trends suggest a potential shift in CKD etiology among HIV-infected populations.

Purpose of the Study:

  • To investigate the association between ethnicity and CKD risk in HIV-infected patients in the Netherlands.
  • To determine if ethnic background influences the prevalence and incidence of CKD in contemporary HIV care.

Main Methods:

  • Analysis of 16,836 patients from the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort.
  • CKD defined as glomerular filtration rate <60 mL/min/1.73 m(2).
  • Examined associations between ethnicity (Sub-Saharan African origin vs. Western European/Australasian origin) and prevalent/incident CKD.

Main Results:

  • The prevalence of CKD at baseline was 2.7%.
  • Sub-Saharan African origin was associated with a higher prevalence of baseline CKD (aOR 1.49).
  • During follow-up, the risk of incident CKD was similar between patients of Sub-Saharan African origin and those of Western European/Australasian origin (aHR 1.00).

Conclusions:

  • In the Netherlands, HIV-infected individuals of Sub-Saharan African origin had a higher prevalence of CKD at baseline.
  • Ethnicity did not influence the development of new CKD over time in this cohort.
  • Findings suggest a potential shift in CKD causes, moving away from HIV-associated nephropathy towards other etiologies.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
525
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
662
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
325
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
367